← Shuttle Pharmaceuticals (SHPH)
Shuttle Pharmaceuticals SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Entry into a material definitive agreement · Unregistered sales of equity securities · Other events · Financial statements and exhibits
AI summary, unreviewedShuttle Pharmaceuticals Holdings issues 6,693,740 milestone pre-funded warrants at $0.001 exercise price, adding dilution against ~4.8M shares outstanding
Change in certifying accountant · Financial statements and exhibits
AI summary, unreviewedShuttle Pharmaceuticals Holdings Replaces Forvis Mazars with Bush & Associates CPA as Auditor Effective November 2, 2026
Change in certifying accountant · Financial statements and exhibits
AI summary, unreviewedShuttle Pharmaceuticals Holdings dismisses auditor Forvis Mazars amid material weaknesses and no replacement engaged
Financial statements and exhibits
Unregistered sales of equity securities · Financial statements and exhibits
Submission of matters to a vote of security holders · Financial statements and exhibits
Other events · Financial statements and exhibits
Entry into a material definitive agreement · Financial statements and exhibits
Delisting notice / failure to meet listing standard · Regulation FD disclosure · Financial statements and exhibits
Completion of acquisition or disposition of assets · Financial statements and exhibits